Public Health Emergency - Leading a Nation Prepared
The Cepheid Xpert Xpress SARS-CoV/Flu/RSV test will detect viral nucleic acid and provides one test that detects and differentiates COVID-19 and Flu during the upcoming Flu season. The test will operate on all of Cepheid’s widely-placed GeneXpert and Infinity systems for laboratory testing, as well as their Xpress instrument in point-of-care settings.
On September 24, 2020, FDA issued an Emergency Use Authorization (EUA) to allow Cepheid’s Xpert Xpress SARS-COV-2/Flu/RSV to be used to detect and differentiate SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA. FDA reissued the EUA on October 1, 2020.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages